Rufini, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 6.309
NA - Nord America 5.476
AS - Asia 1.883
AF - Africa 30
SA - Sud America 18
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.731
Nazione #
US - Stati Uniti d'America 5.432
DE - Germania 2.669
SE - Svezia 935
CN - Cina 911
UA - Ucraina 548
IT - Italia 520
SG - Singapore 492
PL - Polonia 358
GB - Regno Unito 278
IE - Irlanda 278
FR - Francia 266
ID - Indonesia 165
FI - Finlandia 158
IN - India 132
RU - Federazione Russa 122
TR - Turchia 76
BE - Belgio 47
CA - Canada 34
NL - Olanda 31
JP - Giappone 26
CI - Costa d'Avorio 21
CH - Svizzera 19
IR - Iran 18
VN - Vietnam 17
ES - Italia 14
HK - Hong Kong 13
BR - Brasile 12
AT - Austria 11
AU - Australia 11
CZ - Repubblica Ceca 11
LT - Lituania 11
MX - Messico 8
DK - Danimarca 6
PH - Filippine 6
DZ - Algeria 5
GR - Grecia 4
IL - Israele 4
MY - Malesia 4
PE - Perù 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
IQ - Iraq 3
PT - Portogallo 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CU - Cuba 2
EE - Estonia 2
EG - Egitto 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
KZ - Kazakistan 2
RS - Serbia 2
AM - Armenia 1
AR - Argentina 1
BN - Brunei Darussalam 1
CO - Colombia 1
IM - Isola di Man 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 13.731
Città #
Chandler 1.273
Ashburn 394
Singapore 390
Jacksonville 335
Warsaw 330
Dublin 275
San Mateo 257
Ann Arbor 230
Nanjing 221
Nürnberg 199
Jakarta 164
Wilmington 160
Dearborn 156
New York 129
Woodbridge 121
Houston 114
Boston 112
Fairfield 110
Milan 109
Munich 100
Cattolica 92
Marseille 92
Nanchang 89
Bremen 83
Seattle 81
Rome 79
Moscow 75
Lawrence 74
Redwood City 73
Izmir 67
Princeton 67
Lancaster 62
Beijing 61
Zhengzhou 61
Los Angeles 58
Redmond 52
Boardman 50
Hebei 48
Helsinki 47
Brussels 44
Kunming 41
Chicago 39
Mountain View 38
Cambridge 30
Changsha 29
Tianjin 29
Leawood 28
Shenyang 28
Shanghai 27
University Park 26
Jiaxing 25
Detroit 24
Guangzhou 23
Norwalk 22
Pune 22
Abidjan 21
Fremont 20
Toronto 20
Jinan 19
Kraków 19
Hefei 18
London 17
Hangzhou 14
Phoenix 14
Falls Church 13
Augusta 12
Columbus 12
Santa Clara 11
Hanoi 10
Lanzhou 10
Ottawa 10
Palermo 10
Renton 10
Amsterdam 9
Andover 9
Edinburgh 9
Hong Kong 9
San Diego 9
Vienna 9
Wuhan 9
Brno 8
Chengdu 8
Costa Mesa 8
Frankfurt am Main 8
Southend 8
Busto Arsizio 7
Changchun 7
Ningbo 7
Simi Valley 7
Tokyo 7
Dong Ket 6
Fuzhou 6
Indiana 6
Jesi 6
Monmouth Junction 6
Paris 6
Ypsilanti 6
Zurich 6
Arezzo 5
Bern 5
Totale 7.421
Nome #
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 305
Severe thyrotoxicosis due to functioning pulmonary metastases of well-differentiated thyroid cancer 286
Interleukin-31 and thymic stromal lymphopoietin expression in plasma and lymph node from Hodgkin lymphoma patients 237
18F-fluoro-deoxy-glucose focal uptake in very small pulmonary nodules: fact or artifact? Case reports 229
Markedly Increased 18F-FDG Uptake in a Nonfunctioning Adrenal Adenoma Mimicking Malignancy 225
Incidentally discovered adrenal masses: a functional and morphological study 208
A phase II study of sunitinib in advanced hepatocellular carcinoma 206
Renal artery stenting in patients with chronic ischemic heart disease 178
[Contribution of nuclear medicine to the diagnosis of silent adrenal masses] 166
Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors 162
Are the simplified methods to estimate Ki in 18F-FDG PET studies feasible in clinical routine? Comparison between three simplified methods. 162
Complete Metabolic Response with Recanalization of Portal Vein Tumor Thrombosis after Sunitinib in a Patient with Advanced Hepatocellular Carcinoma 159
A prospective analysis of ¹⁸F-FDG PET/CT in patients with uveal melanoma: comparison between metabolic rate of glucose (MRglu) and standardized uptake value (SUV) and correlations with histopathological features. 157
Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma. 156
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 154
A NEW APPROACH IN THE TREATMENT OF STAGE-IV NEUROBLASTOMA USING A OMBINATION OF {[I-131] METAIODOBENZYLGUANIDINE (MIBG) AND CISPLATIN} 132
Radio-guided surgery for lymph node recurrences of differentiated thyroid cancer 131
A Rare Case of Ectopic Adrenocorticotropic Hormone Syndrome Caused by a Metastatic Neuroendocrine Tumor of the Pancreas Detected by 68Ga-DOTANOC and 18F-FDG PET/CT 131
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 130
Radiolabeled somatostatin analog scintigraphy in medullary thyroid carcinoma and carcinoid tumor 128
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 126
Treatment of advanced neuroblastoma in children over 1 year of age: The critical role of (131) I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen. 123
Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography 123
Oncological outcome in advanced laryngeal cancers treated with different modalities in a single institution. A retrospective analysis on 65 cases. 121
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography. 121
Oncologic outcomes in advanced laryngeal squamous cell carcinomas treated with different modalities in a single institution: a retrospective analysis of 65 cases 120
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature 120
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 117
Cardiac metastases of Ewing sarcoma detected by 18F-FDG PET/CT 116
Diagnostic imaging of euthyroid goiter 116
imaging of peritoneal carcinomatosis with FDG PET-CT: diagnostic patterns, case examples and pitfalls 114
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study. 113
Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. 112
Cushing's syndrome due to a bronchial ACTH-secreting carcinoid successfully treated with radio frequency ablation (RFA) 111
Validity of thyroglobulin mRNA assay in peripheral blood of postoperative thyroid carcinoma patients in predicting tumor recurrences varies according to the histologic type: results of a prospective study 110
Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography 110
Interim FDG-PET/CT in Hodgkin lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET). 110
Taralli S, Sollini M, Milella M, Perotti G, Filice A, Menga M, Versari A, Rufini V. (18)F-FDG and (68)Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study. 110
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 109
Physiological Activity of Spinal Cord in Children: An 18F-FDG PET-CT Study 109
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 108
Can "early" and "late"18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? 107
Role of PET/CT in the functional imaging of endocrine pancreatic tumors 103
Diagnostic imaging in thyrotoxicosis 103
Recurrence in region of spared parotid gland in patient receiving definitive intensity-modulated radiotherapy for nasopharyngeal cancer: A case report 103
Scintigraphic localization of a disseminated malignant pheochromocytoma with the use of 131I-meta-iodobenzylguanidine 103
Optimal use of the 131-I-metaiodobenzylguanidine and cisplatin combination in advanced neuroblastoma 102
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 102
Pharmacological interference with 123I-metaiodobenzylguanidine: a limitation to developing cardiac innervation imaging in clinical practice? 102
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 100
Lung uptake of fluorine-18 fluoroethyl-choline PET-CT in patients with prostate cancer 100
Imaging techniques for the evaluation of cervical cancer 99
Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid 99
Masking effect of chronic pancreatitis in the interpretation of somatostatin receptor positron emission tomography in pancreatic neuroendocrine tumors. 98
Primary multifocal lymphoma of peripheral nervous system: Case report and review of the literature 97
(18)F-Fluorodeoxyglucose positron emission tomography in evaluating treatment response to imatinib or other drugs in gastrointestinal stromal tumors: a systematic review 96
A Rare Case of Solitary Fibrous Tumor of the Adrenal Gland Detected by 18F-FDG PET/CT 96
Diagnostic imaging of the thyroid: metodology and norma patterns 95
The role of positron emission tomography using carbon-11 and fluorine-18 choline in tumors other than prostate cancer: a systematic review 94
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 93
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma 92
Comparison of 123I-MIBG SPECT-CT and 18F-DOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma 92
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 92
Thyrotoxicosis due to ectopic retrotracheal adenoma treated with radioiodine 91
Liver metastases of endocrine tumour associated with multiple endocrine neoplasia type 1: a sustained response to interferon therapy or a peculiar benign course? 91
Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma 91
A rare case of synchronous bilateral pulmonary neuroendocrine tumor detected by 68Ga-DOTANOC PET/CT 90
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 90
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 88
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome 88
Unusual increased metaiodobenzylguanidine uptake in liposarcoma 87
Thyroid carcinomas with a variable insular component: prognostic significance of histopathologic patterns 87
CRITICAL OBSERVATIONS ON NEUROBLASTOMA TREATMENT WITH 131-I-METAIODOBENZYLGUANIDINE AT DIAGNOSIS 86
A standardized dual-phase 18F-DOPA PET/CT protocol in the detection of medullary thyroid cancer 86
Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma 85
Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumors: a meta-analysis 85
Which imaging technique should we use in the follow up of gynaecological cancer? 85
Radiolabeled mataiodobenzylguanidine in the diagnosis of neural crest tumors 84
Intrapancreatic Accessory Spleen Detected by 68Ga DOTANOC PET/CT and 99mTc-Colloid SPECT/CT Scintigraphy 84
Diagnostic performance of (18)F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis 83
A Case of Insulinoma Detected by 68Ga-DOTANOC PET/CT and Missed by 18F-Dihydroxyphenylalanine PET/CT 81
Multifocal Extra-Adrenal Paraganglioma Evaluated With Different PET Tracers: Comparison Between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT 81
A rare case of solitary fibrous tumor of the adrenal gland detected by (18)F-FDG PET/CT 81
Pulmonary Neuroendocrine Tumor Incidentally Detected by 18F-CH PET/CT 79
FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUVmax (rPET) 79
Detection Rate of Recurrent Medullary Thyroid Carcinoma Using Fluorine-18 Dihydroxyphenylalanine Positron Emission Tomography: A Meta-analysis 78
I-131 METAIODOBENZYLGUANIDINE IN THE TREATMENT OF NEUROBLASTOMA AT DIAGNOSIS 77
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls 76
Imaging in endocrinology: 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in differentiated thyroid carcinoma: clinical indications and controversies in diagnosis and follow-up 76
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient With Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 76
An unusual case of adrenal metastasis from colorectal cancer: computed tomography and fluorine 18-fluoro-deoxy-glucose positron emission tomography-computed tomography features and literature review 75
The impact of the COVID-19 pandemic on oncological disease extent at FDG PET/CT staging: the ONCOVIPET study 75
TREATMENT OF NEUROBLASTOMA WITH I-131 METAIODOBENZYLGUANIDINE 73
Groin sentinel node biopsy and18F-FDG PET/CT-supported preoperative lymph node assessment in cN0 patients with vulvar cancer currently unfit for minimally invasive inguinal surgery: The GroSNaPET study 73
Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. 72
Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma 72
68Ga-DOTATOC PET/CT in Pleural Solitary Fibrous Tumors 72
Accessory spleen is an important pitfall of 68Ga-DOTANOC-PET CT in the workup for pancreatic neuroendcorine neoplasm 71
The PRICE study: The role of conventional and diffusion-weighted magnetic resonance imaging in assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. 71
Improved Detection of Minimal Residual Disease by 11C-Methionine PET/CT in a Young Patient with Unusual Extramedullary Presentation of Recurrent Multiple Myeloma 68
Totale 11.216
Categoria #
all - tutte 54.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.765


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.294 0 0 0 0 158 228 175 70 174 136 209 144
2020/20211.255 64 152 46 126 170 77 162 26 142 68 196 26
2021/20221.391 125 124 11 98 103 48 29 212 71 65 204 301
2022/20233.339 393 460 202 564 181 421 168 297 393 58 117 85
2023/20241.410 77 430 43 64 44 206 46 68 23 87 168 154
2024/2025846 80 75 256 121 314 0 0 0 0 0 0 0
Totale 13.904